Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
Authors
Keywords
Magnetic resonance spectroscopy, Glutamate, Cannabis, Early psychosis, Cognition
Journal
PSYCHOPHARMACOLOGY
Volume 235, Issue 1, Pages 13-22
Publisher
Springer Nature
Online
2017-10-26
DOI
10.1007/s00213-017-4745-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users
- (2016) Valentina Lorenzetti et al. BIOLOGICAL PSYCHIATRY
- Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
- (2016) Marco Colizzi et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use
- (2016) Rebecca C. Hanna et al. SCHIZOPHRENIA BULLETIN
- Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis
- (2016) Lijing Xin et al. SCHIZOPHRENIA BULLETIN
- Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4 Tesla 1 H-MRS study
- (2016) Denise Bernier et al. SCHIZOPHRENIA RESEARCH
- Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A 1H MRS Study at 7Tesla
- (2016) Allison S. Brandt et al. SCHIZOPHRENIA RESEARCH
- Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence
- (2016) Devi Treen et al. SCHIZOPHRENIA RESEARCH
- Nature of Glutamate Alterations in Schizophrenia
- (2016) Kate Merritt et al. JAMA Psychiatry
- Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study
- (2016) Edith Liemburg et al. Scientific Reports
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Simultaneous quantification of glutamate and glutamine by J-modulated spectroscopy at 3 Tesla
- (2015) Yan Zhang et al. MAGNETIC RESONANCE IN MEDICINE
- Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex
- (2015) Tiziana Rubino et al. NEUROBIOLOGY OF DISEASE
- In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: Application to schizophrenia
- (2015) S. Andrea Wijtenburg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effect of high-potency cannabis on corpus callosum microstructure
- (2015) S. Rigucci et al. PSYCHOLOGICAL MEDICINE
- Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
- (2014) Tom P. Freeman et al. ADDICTION
- γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers
- (2013) Andrew P. Prescot et al. DRUG AND ALCOHOL DEPENDENCE
- Treatment and Early Intervention in Psychosis Program (TIPP-Lausanne): implementation of an early intervention programme for psychosis in Switzerland
- (2013) Philipp Sebastian Baumann et al. Early Intervention in Psychiatry
- Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats
- (2013) Erica Zamberletti et al. NEUROBIOLOGY OF DISEASE
- Reduced Frontal Glutamate + Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia
- (2013) Tatsunobu Natsubori et al. SCHIZOPHRENIA BULLETIN
- In vivo 1H magnetic resonance spectroscopy in young-adult daily marijuana users
- (2013) Ryan L. Muetzel et al. NeuroImage-Clinical
- Cannabis use before age 15 and subsequent executive functioning
- (2011) Maria Alice Fontes et al. BRITISH JOURNAL OF PSYCHIATRY
- Neurochemical alterations in adolescent chronic marijuana smokers: A proton MRS study
- (2011) Andrew P. Prescot et al. NEUROIMAGE
- Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
- (2011) Anouk Marsman et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs
- (2009) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T
- (2009) Ralf Mekle et al. MAGNETIC RESONANCE IN MEDICINE
- The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex
- (2009) T. Rubino et al. NEUROTOXICITY RESEARCH
- Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus
- (2009) So Young Yoo et al. SCHIZOPHRENIA RESEARCH
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia
- (2008) Scot E. Purdon et al. SCHIZOPHRENIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started